Alanine Mutants of the Interface Residues of Human Thymidylate Synthase Decode Key Features of the Binding Mode of Allosteric Anticancer Peptides

MLA

Janet Finer-Moore, et al. “Alanine Mutants of the Interface Residues of Human Thymidylate Synthase Decode Key Features of the Binding Mode of Allosteric Anticancer Peptides.” Journal of Medicinal Chemistry, vol. 58, Dec. 2014, pp. 1012–18. EBSCOhost, https://doi.org/10.1021/jm5011176.

APA

Janet Finer-Moore, Giambattista Guaitoli, Maria Paola Costi, Anna Tochowicz, Matteo Trande, Robert M. Stroud, Puneet Saxena, & Matteo Santucci. (2014). Alanine Mutants of the Interface Residues of Human Thymidylate Synthase Decode Key Features of the Binding Mode of Allosteric Anticancer Peptides. Journal of Medicinal Chemistry, 58, 1012–1018. https://doi.org/10.1021/jm5011176

Chicago

Janet Finer-Moore, Giambattista Guaitoli, Maria Paola Costi, Anna Tochowicz, Matteo Trande, Robert M. Stroud, Puneet Saxena, and Matteo Santucci. 2014. “Alanine Mutants of the Interface Residues of Human Thymidylate Synthase Decode Key Features of the Binding Mode of Allosteric Anticancer Peptides.” Journal of Medicinal Chemistry 58 (December): 1012–18. doi:10.1021/jm5011176.